EUVIMEDEUVIMED entdecken
Open Access

Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies

Hoang Anh T Phan iD, Soomin Eom iD, Daniel Hwang iD, Michael C Young iD, Shirley M Sun iD, Molly C Erdman iD, Yi Sun iD, Leena Mallik, Photis Rotsides iD, Mark M Painter iD, E John Wherry iD, Dimitri S Monos iD und 1 weitere

Science Advances · 12.06.2026 · 12 (24)

DOI: 10.1126/sciadv.adv2687 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 12.06.2026. Verfasst von Hoang Anh T Phan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computational and Genomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Nanoparticles, Histocompatibility Antigens Class I, CD8-Positive T-Lymphocytes, High-Throughput Screening Assays. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

MHC-I proteins present epitopic peptides to CD8 + T cells to elicit multifaceted adaptive immune responses. The affinity and avidity of interactions between peptide-MHC molecules and their cognate T cell receptors (TCRs) are fundamental parameters that contribute to the induction of activated or anergic T cell states. Here, we present a multivalent, loadable platform, VLP-Open HLA, featuring a virus-like particle (VLP) which can display up to 60 peptide/HLA [human leukocyte antigen (HLA)] molecules. VLP-Open HLA can be used to stain antigen-specific CD8 + T cells, providing a screening tool for orphan TCRs. When combined with costimulation, VLP-Open HLA acts as an artificial antigen-presenting platform to induce antigen-specific T cell activation and expansion, providing a facile alternative to autologous antigen-presenting cells. Our platform can be adapted to encompass multiple HLA allotypes and costimulatory molecules as mosaic nanoparticles, enabling a range of applications in experimental immunology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesHistocompatibility Antigens Class ICD8-Positive T-LymphocytesHigh-Throughput Screening AssaysT-LymphocytesHumansLymphocyte ActivationPeptidesReceptors, Antigen, T-CellAntigen Presentation

Substanzen

Histocompatibility Antigens Class IPeptidesReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Center for Computational and Genomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cancer Biology Graduate Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
  • Institute for Immunology and Immune Health, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

ORCID-Profile: Hoang Anh T Phan, Soomin Eom, Daniel Hwang, Michael C Young, Shirley M Sun, Molly C Erdman, Yi Sun, Photis Rotsides, Mark M Painter, E John Wherry, Dimitri S Monos, Nikolaos G Sgourakis

Förderung

  • National Institutes of Health
  • National Cancer Institute
  • National Institute of General Medical Sciences
  • National Institute of Allergy and Infectious Diseases
  • Cancer Research UK
  • Children's Hospital of Philadelphia
  • NIAID

Zitieren

APA

Phan, H. A. T., Eom, S., Hwang, D., Young, M. C., Sun, S. M., Erdman, M. C., Sun, Y., Mallik, L., Rotsides, P., Painter, M. M., Wherry, E. J., Monos, D. S., & Sgourakis, N. G. (2026). Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies. Science Advances, 12(24). https://doi.org/10.1126/sciadv.adv2687

Vancouver

Phan HAT, Eom S, Hwang D, Young MC, Sun SM, Erdman MC, et al. Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies. Science Advances. 2026;12(24). doi:10.1126/sciadv.adv2687

BibTeX
@article{Phan2026,
  author = {Phan, Hoang Anh T and Eom, Soomin and Hwang, Daniel and Young, Michael C and Sun, Shirley M and Erdman, Molly C and Sun, Yi and Mallik, Leena and Rotsides, Photis and Painter, Mark M and Wherry, E John and Monos, Dimitri S and Sgourakis, Nikolaos G},
  title = {Ready-to-load MHC-I nanoparticles for high-throughput T cell screening studies},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {24},
  doi = {10.1126/sciadv.adv2687}
}
Kostenlos starten →